Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran.

about

Association of clinicopathologic characteristics and outcomes with EZH2 expression in patients with breast cancer in East Azerbaijan, Iran.

Item

http://www.wikidata.org/entity/Q49344192

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Association of clinicopatholog ...... ncer in East Azerbaijan, Iran.

@en

Association of clinicopatholog ...... ncer in East Azerbaijan, Iran.

@nl

type

Item

label

Association of clinicopatholog ...... ncer in East Azerbaijan, Iran.

@en

Association of clinicopatholog ...... ncer in East Azerbaijan, Iran.

@nl

prefLabel

Association of clinicopatholog ...... ncer in East Azerbaijan, Iran.

@en

Association of clinicopatholog ...... ncer in East Azerbaijan, Iran.

@nl

P1476

Association of clinicopatholog ...... ancer in East Azerbaijan, Iran

@en

P2093

Ashraf Fakhrjou

http://www.w3.org/2001/XMLSchema#string

Faris Farassati

http://www.w3.org/2001/XMLSchema#string

Farnaz Boostani

http://www.w3.org/2001/XMLSchema#string

Zohreh Sanaat

http://www.w3.org/2001/XMLSchema#string

P2860

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Prognostic value of high EZH2 expression in patients with different types of cancer: a systematic review with meta-analysis

EZH2 expression in invasive lobular carcinoma of the breast.

EZH2, a unique marker of malignancy in effusion cytology.

The methyltransferase EZH2 is not required for mammary cancer development, although high EZH2 and low H3K27me3 correlate with poor prognosis of ER-positive breast cancers

Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis

Significance of EZH2 expression in canine mammary tumors.

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions.

High EZH2 Protein Expression Is Associated with Poor Overall Survival in Patients with Luminal A Breast Cancer

EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features.

P304

449-457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S149210

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roya Dolatkhah

P577

2018-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29403289

http://www.w3.org/2001/XMLSchema#string

P932

5783027

http://www.w3.org/2001/XMLSchema#string